Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women.

BACKGROUND Few clinical trials have evaluated interventions for major depressive disorder in samples of low-income minority women, and little is known about the cost-effectiveness of depression interventions for this population. OBJECTIVE To evaluate the cost-effectiveness of pharmacotherapy or cognitive behavior therapy (CBT) compared with community referral for major depression in low-income minority women. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial was conducted in 267 women with current major depression. INTERVENTIONS Participants were randomly assigned to pharmacotherapy (paroxetine hydrochloride or bupropion hydrochloride) (n = 88), CBT (n = 90), or community referral (n = 89). MAIN OUTCOME MEASURES The main outcomes were intervention and health care costs, depression-free days, and quality-adjusted life years based on Hamilton Depression Rating Scale scores and Medical Outcomes Study 36-Item Short-Form Health Survey summary scores for 12 months. Cost-effectiveness ratios were estimated to compare incremental patient outcomes with incremental costs for pharmacotherapy relative to community referral and for CBT relative to community referral. RESULTS Compared with the community referral group, the pharmacotherapy group had significantly lower adjusted mean Hamilton Depression Rating Scale scores from the 3rd month through the 10th month (P = .04 to P<.001) of the study, and the CBT group had significantly lower adjusted mean scores from the 5th month through the 10th month (P = .03 to P = .049). There were significantly more depression-free days in the pharmacotherapy group (mean, 39.7; 95% confidence interval, 12.9-66.5) and the CBT group (mean, 25.80; 95% confidence interval, 0.04-51.50) than in the community referral group. The cost per additional depression-free day was USD 24.65 for pharmacotherapy and USD 27.04 for CBT compared with community referral. CONCLUSIONS Effective treatment for depression in low-income minority women reduces depressive symptoms but increases costs compared with community referral. The pharmacotherapy and CBT interventions were cost-effective relative to community referral for the health care system.

[1]  Juned Siddique,et al.  Treating depression in predominantly low-income young minority women: a randomized controlled trial. , 2003, JAMA.

[2]  C. Sherbourne,et al.  Improving care for minorities: can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial. , 2003, Health services research.

[3]  W. Katon,et al.  Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. , 2001, The American journal of psychiatry.

[4]  C. Sherbourne,et al.  Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. , 2001, JAMA.

[5]  C. Sherbourne,et al.  Long-term effectiveness of disseminating quality improvement for depression in primary care. , 2001, Archives of general psychiatry.

[6]  R. Kessler,et al.  Recent care of common mental disorders in the united states , 2000, Journal of General Internal Medicine.

[7]  W. Manning,et al.  Randomized trial of a depression management program in high utilizers of medical care. , 2000, Archives of family medicine.

[8]  Michael VonKorff,et al.  Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care , 2000, BMJ : British Medical Journal.

[9]  C. Sherbourne,et al.  Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. , 2000, JAMA.

[10]  W. Katon,et al.  Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial. , 1999, Archives of family medicine.

[11]  J. Lave,et al.  Cost-effectiveness of treatments for major depression in primary care practice. , 1998, Archives of general psychiatry.

[12]  W. Katon,et al.  Treatment Costs, Cost Offset, and Cost-Effectiveness of Collaborative Management of Depression , 1998, Psychosomatic medicine.

[13]  D A Revicki,et al.  Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. , 1998, Journal of affective disorders.

[14]  W. Katon,et al.  A multifaceted intervention to improve treatment of depression in primary care. , 1996, Archives of general psychiatry.

[15]  A R Willan,et al.  Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. , 1996, Health economics.

[16]  W. Katon,et al.  Initial antidepressant choice in primary care , 1996 .

[17]  Tammy O. Tengs,et al.  Five-hundred life-saving interventions and their cost-effectiveness. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[18]  W. Katon,et al.  Collaborative management to achieve treatment guidelines. Impact on depression in primary care. , 1995, JAMA.

[19]  K Kroenke,et al.  Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. , 1994, JAMA.

[20]  Janet B W Williams,et al.  A structured interview guide for the Hamilton Depression Rating Scale. , 1988, Archives of general psychiatry.

[21]  R. Little.  Missing-Data Adjustments in Large Surveys , 1988 .

[22]  R. Sugden.  Multiple Imputation for Nonresponse in Surveys , 1988 .

[23]  E. R. Barnhart,et al.  Physicians Desk Reference (PDR) , 1977 .

[24]  J. Ware.  SF-36 health survey: Manual and interpretation guide , 2003 .

[25]  D. Revicki,et al.  The Economics of Selective Serotonin Reuptake Inhibitors In Depression , 2001, CNS drugs.

[26]  C. Sherbourne,et al.  The quality of care for depressive and anxiety disorders in the United States. , 2001, Archives of general psychiatry.

[27]  D. Satcher.  Mental Health: Culture, Race, and Ethnicity—A Supplement to Mental Health: A Report of the Surgeon General , 2001 .

[28]  R. Muñoz,et al.  Group Therapy Manual for Cognitive-Behavioral Treatment of Depression: , 2000 .

[29]  R. F. Muñoz,et al.  Manual de Terapia de Grupo para el Tratamiento Cognitivo-Conductual Depresión , 2000 .

[30]  N. Blomqvist,et al.  Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. , 1998, Statistics in medicine.

[31]  John E. Ware,et al.  SF-36 physical and mental health summary scales : a user's manual , 1994 .